Search Results - "Olivotto, A"

Interim Cosmetic and Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal External Beam Radiation Therapy by OLIVOTTO, Ivo A, WHELAN, Timothy J, GERMAIN, Isabelle, AKRA, Mohamed, REED, Melanie, FYLES, Anthony, TROTTER, Theresa, PERERA, Francisco, BECKHAM, Wayne, LEVINE, Mark N, JULIAN, Jim A, PARPIA, Sameer, KIM, Do-Hoon, BERRANG, Tanya, TRUONG, Pauline T, KONG, Iwa, COCHRANE, Brandy, NICHOL, Alan, ROY, Isabelle

“…To report interim cosmetic and toxicity results of a multicenter randomized trial comparing accelerated partial-breast irradiation (APBI) using…”
Get full text

Volumetric Modulated Arc Therapy Improves Dosimetry and Reduces Treatment Time Compared to Conventional Intensity-Modulated Radiotherapy for Locoregional Radiotherapy of Left-Sided Breast Cancer and Internal Mammary Nodes by Popescu, Carmen C., M.S, Olivotto, Ivo A., M.D, Beckham, Wayne A., Ph.D, Ansbacher, Will, Ph.D, Zavgorodni, Sergei, Ph.D, Shaffer, Richard, F.R.C.P, Wai, Elaine S., M.D, Otto, Karl, Ph.D

“…Purpose Volumetric modulated arc therapy (VMAT) is a novel extension of conventional intensity-modulated radiotherapy (cIMRT), in which an optimized…”
Get full text

Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial by Pignol, Jean-Philippe, Truong, Pauline, Rakovitch, Eileen, Sattler, Margriet G, Whelan, Timothy J, Olivotto, Ivo A

“…Abstract Background and purpose We report the long-term outcomes in patients enrolled in a multicenter randomized controlled trial comparing Intensity…”
Get full text

Impact on Survival of Time From Definitive Surgery to Initiation of Adjuvant Chemotherapy for Early-Stage Breast Cancer by LOHRISCH, Caroline, PALTIEL, Charles, GELMON, Karen, SPEERS, Caroline, TAYLOR, Suzanne, BARNETT, Jeff, OLIVOTTO, Ivo A

“…To determine if time to start of adjuvant chemotherapy after curative surgery influences survival in early-stage breast cancer. A retrospective review was…”
Get full text

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers by CHIA, Stephen, NORRIS, Brian, SPEERS, Caroline, CHEANG, Maggie, GILKS, Blake, GOWN, Allen M, HUNTSMAN, David, OLIVOTTO, Ivo A, NIELSEN, Torsten O, GELMON, Karen

“…Human epidermal growth factor receptor 2 gene (HER2) is associated with a poorer outcome in node-positive breast cancer, but the results are conflicting in…”
Get full text

Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer by OLIVOTTO, Ivo A, BAJDIK, Chris D, RAVDIN, Peter M, SPEERS, Caroline H, COLDMAN, Andrew J, NORRIS, Brian D, DAVIS, Greg J, CHIA, Stephen K, GELMON, Karen A

“…Adjuvant! (www.adjuvantonline.com) is a web-based tool that predicts 10-year breast cancer outcomes with and without adjuvant systemic therapy, but it has not…”
Get full text

Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial by Ragaz, Joseph, Olivotto, Ivo A., Spinelli, John J., Phillips, Norman, Jackson, Stewart M., Wilson, Kenneth. S., Knowling, Margaret A., Coppin, Christopher M. L., Weir, Lorna, Gelmon, Karen, Le, Nhu, Durand, Ralph, Coldman, Andrew J., Manji, Mohamed

“…Background: The British Columbia randomized radiation trial was designed to determine the survival impact of locoregional radiation therapy in premenopausal…”
Get full text

Evolving Treatment Strategies for Inflammatory Breast Cancer: A Population-Based Survival Analysis by PANADES, Miguel, OLIVOTTO, Ivo A, SPEERS, Caroline H, SHENKIER, Tamara, OLIVOTTO, Theodora A, WEIR, Lorna, ALLAN, Sharon J, TRUONG, Pauline T

“…To determine if mastectomy (Mx) use, chemotherapy (CT) intensity, or treatment sequence of CT, radiation therapy (RT), and Mx have improved outcome for…”
Get full text

Reliability and validity testing of the patient and observer scar assessment scale in evaluating linear scars after breast cancer surgery by TRUONG, Pauline T, LEE, Junella C, SOER, Benjamin, GAUL, Catherine A, OLIVOTTO, Ivo A

“…The Patient and Observer Scar Assessment Scale is a promising new method incorporating observer and patient ratings in evaluating burn scars. The authors…”
Get full text

Predictors of Adverse Cosmetic Outcome in the RAPID Trial: An Exploratory Analysis by Peterson, David, MD, Truong, Pauline T., MD, Parpia, Sameer, PhD, Olivotto, Ivo A., MD, Berrang, Tanya, MD, Kim, Do-Hoon, MD, Kong, Iwa, MD, Germain, Isabelle, MD, Nichol, Alan, MD, Akra, Mohamed, MD, Roy, Isabelle, MD, Reed, Melanie, MD, Fyles, Anthony, MD, Trotter, Theresa, MD, Perera, Francisco, MD, Balkwill, Susan, MD, Lavertu, Sophie, MD, Elliott, Elizabeth, MRT(T), CCRP, Julian, Jim A., M.Math, Levine, Mark N., MD, Whelan, Timothy J., BM, BCh

“…Purpose To evaluate factors associated with adverse cosmesis outcome in breast cancer patients randomized to accelerated partial breast irradiation (APBI)…”
Get full text

Chronic Arm Morbidity After Curative Breast Cancer Treatment: Prevalence and Impact on Quality of Life by KWAN, Winkle, JACKSON, Jeremy, WEIR, Lorna M, DINGEE, Carol, MCGREGOR, Greg, OLIVOTTO, Ivo A

“…To determine the prevalence of and contributing factors for chronic arm morbidity including lymphedema in breast cancer patients after treatment and to assess…”
Get full text

Immunohistochemical Detection Using the New Rabbit Monoclonal Antibody SP1 of Estrogen Receptor in Breast Cancer Is Superior to Mouse Monoclonal Antibody 1D5 in Predicting Survival by CHEANG, Maggie C. U, TREABA, Diana O, NIELSEN, Torsten O, GOWN, Allen M, SPEERS, Caroline H, OLIVOTTO, Ivo A, BAJDIK, Chris D, CHIA, Stephen K, GOLDSTEIN, Lynn C, GELMON, Karen A, HUNTSMAN, David, BLAKE GILKS, C

“…Estrogen receptor (ER) expression predicts improved breast cancer-specific survival and reduced risk of recurrence and is targeted in breast cancer therapy. A…”
Get full text

A Quantitative Analysis of the Relationship Between Radiation Therapy Use and Travel Time by Liu, Emma, MM, Santibáñez, Pablo, MM, Puterman, Martin L., PhD, Weber, Leah, MM, Ma, Xiang, MM, Sauré, Antoine, PhD, Olivotto, Ivo A., MD, Halperin, Ross, MD, French, John, MSc, Tyldesley, Scott, MD

“…Purpose To model and quantify the relationship between radiation therapy (RT) use and travel time to RT services. Methods and Materials Population-based…”
Get full text

Impact of Quality Assurance Rounds in a Canadian Radiation Therapy Department by Lefresne, Shilo, BSc, MD, Olivotto, Ivo A., MD, FRCPC, Joe, Howard, MD, FRCPC, Blood, Paul A., BM, FRCPC, PhD, Olson, Robert A., MD, FRCPC, MSc

“…Purpose Quality assurance (QA) programs aim to identify inconsistencies that may compromise patient care. Radiation treatment planning is a well-documented…”
Get full text

Impact of Using Audit Data to Improve the Evidence-Based Use of Single-Fraction Radiation Therapy for Bone Metastases in British Columbia by Olson, Robert A., MD, MSc, Tiwana, Manpreet, MD, Barnes, Mark, MSc, Cai, Eric, McGahan, Colleen, MSc, Roden, Kelsey, BSc, Yurkowski, Emily, Gentles, Quinn, BSc, French, John, MSc, Halperin, Ross, MD, Olivotto, Ivo A., MD

“…Purpose To assess the impact of a population-based intervention to increase the consistency and use of single-fraction radiation therapy (SFRT) for bone…”
Get full text

Validation of a Web-Based Predictive Nomogram for Ipsilateral Breast Tumor Recurrence After Breast Conserving Therapy by SANGHANI, Mona, TRUONG, Pauline T, ABI RAAD, Rita, NIEMIERKO, Andrzej, LESPERANCE, Mary, OLIVOTTO, Ivo A, WAZER, David E, TAGHIAN, Alphonse G

“…PURPOSE IBTR! version 1.0 is a web-based tool that uses literature-derived relative risk ratios for seven clinicopathologic variables to predict ipsilateral…”
Get full text

Should Women Younger Than 40 Years of Age With Invasive Breast Cancer Have a Mastectomy?: 15-Year Outcomes in a Population-Based Cohort by Cao, Jeffrey Q., MD, MBA, FRCPC, Truong, Pauline T., MD, FRCPC, Olivotto, Ivo A., MD, FRCPC, Olson, Robert, MD, FRCPC, MSc, Coulombe, Genevieve, MD, FRCPC, Keyes, Mira, MD, FRCPC, Weir, Lorna, MD, FRCPC, Gelmon, Karen, MD, FRCPC, Bernstein, Vanessa, MD, FRCPC, Woods, Ryan, MSc, Speers, Caroline, BA, Tyldesley, Scott, MD, FRCPC

“…Purpose Optimal local management for young women with early-stage breast cancer remains controversial. This study examined 15-year outcomes among women younger…”
Get full text

Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer by Ragaz, Joseph, Jackson, Stewart M, Le, Nhu, Plenderleith, Ian H, Spinelli, John J, Basco, Vivian E, Wilson, Kenneth S, Knowling, Margaret A, Coppin, Christopher M.L, Paradis, Marilyn, Coldman, Andrew J, Olivotto, Ivo A

“…Trials of postoperative radiotherapy for breast cancer conducted during the 1960s and 1970s showed significant reductions in rates of locoregional recurrence…”
Get full text

Intervals Longer Than 20 Weeks From Breast-Conserving Surgery to Radiation Therapy Are Associated With Inferior Outcome for Women With Early-Stage Breast Cancer Who Are Not Receiving Chemotherapy by OLIVOTTO, Ivo A, LESPERANCE, Mary L, KWAN, Winkle, KENNECKE, Hagen, TRUONG, Pauline T, NICHOL, Alan, BERRANG, Tanya, TYLDESLEY, Scott, GERMAIN, Francois, SPEERS, Caroline, WAI, Elaine, HOLLOWAY, Caroline

“…To determine the interval from breast-conserving surgery (BCS) to radiation therapy (RT) that affects local control or survival. The 10-year Kaplan-Meier (KM)…”
Get full text

Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast Cancer by Fyles, Anthony W, McCready, David R, Manchul, Lee A, Trudeau, Maureen E, Merante, Patricia, Pintilie, Melania, Weir, Lorna M, Olivotto, Ivo A

“…This randomized trial compared local radiotherapy plus tamoxifen with tamoxifen alone in women 50 years of age or older who had undergone breast-conserving…”
Get full text